Anavex Life Sciences
AVXL
#7501
Rank
S$0.53 B
Marketcap
S$5.98
Share price
-4.28%
Change (1 day)
-53.78%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -S$61.69 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$65.59 Million a decrease over its 2023 earnings that were of -S$57.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$61.69 Million-5.94%
2024 -S$65.59 Million14.77%
2023 -S$57.15 Million-17.49%
2022 -S$69.26 Million22.96%
2021 -S$56.33 Million35.36%
2020 -S$41.61 Million12.65%
2019 -S$36.94 Million29.09%
2018 -S$28.62 Million36.33%
2017 -S$20.99 Million17.11%
2016 -S$17.93 Million20.91%
2015 -S$14.83 Million-6.29%
2014 -S$15.82 Million337.28%
2013 -S$3.62 Million
2008 -S$6.69 Million106.01%
2007 -S$3.25 Million8848.98%
2006 -S$0.04 Million-79.99%
2005 -S$0.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
S$84.96 M-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$83.41 M-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$6.1 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$8.42 Million-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA